ORMAT TECHNOLOGIES, INC.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO (principal executive officer) and CFO (principal financial officer), as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by SEC Rule 13a-15(e), we carried out an evaluation, under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures as of December 31, 2025. Based on this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of December 31, 2025 to provide the reasonable assurance described above.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including the CEO and the CFO, we carried out an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2025 using the criteria established in “Internal Control-Integrated Framework” (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2025.

Our internal control over financial reporting as of December 31, 2025 has been audited by Kesselman & Kesselman, Certified Public Accountants (Isr.), an independent registered public accounting firm and a member of PricewaterhouseCoopers International Limited (“PwC”), as stated in their report which is included under “Item 8—Financial Statements.”

(a)None.

(b)Each of Jessica Woelfel, the General Counsel, Chief Compliance Office and Corporate Secretary, and Ofer Ben Yosef, the Executive Vice President – Energy Storage and Business Development, modified their existing “Rule 10b5-1 trading arrangements” (as defined in Item 408(a) of Regulation S-K), on November 25, 2025 and December 12, 2025, respectively. The modified Rule 10b5-1 trading arrangements provide for the sale of up to, in Ms. Woelfel’s case,11,662 shares underlying equity awards (assuming maximum payouts under outstanding PSUs) until the earlier of May 8, 2026 or the completion of all transactions under her plan, and in Mr. Ben Yosef’s case,23,144 shares underlying equity awards (assuming maximum payouts under outstanding PSUs), until the earlier of December 10, 2027 or the completion of all transactions under his plan. For SEC disclosure purposes, the modifications are considered terminations of these officers’ previously disclosed Rule 10b5-1 trading arrangements (adopted by Ms. Woelfel on June 30, 2025 and Mr. Ben Yosef on June 26, 2025, respectively) and adoptions of new Rule 10b5-1 trading arrangements.

Except as described above, during the fiscal quarter ended December 31, 2025, none of our directors or officers adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.